Loading…

COVID-19 home monitoring program: Healthcare innovation in developing, maintaining, and impacting the outcome of SARS-CoV-2 infected patients

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had caused an increased burden on healthcare organizations. Thus, a new strategy is needed to ensure all COVID-19 positive cases appropriately followed up , to receive the proper medical and psychological support, and to comply with th...

Full description

Saved in:
Bibliographic Details
Published in:Travel medicine and infectious disease 2021-09, Vol.43, p.102089-102089, Article 102089
Main Authors: Al-Tawfiq, Jaffar A., Kheir, Hatim, Al-Dakheel, Talal, Al-Qahtani, Saeed, AlKhadra, Hussain, Sarhan, Ahlam, Bu Halaiga, Maryam, Ibrahim, Rana
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c487t-4ec455792195f2975a7927530a70380e3b2ad9f88c401d87ff5e3a20c3914c0e3
cites cdi_FETCH-LOGICAL-c487t-4ec455792195f2975a7927530a70380e3b2ad9f88c401d87ff5e3a20c3914c0e3
container_end_page 102089
container_issue
container_start_page 102089
container_title Travel medicine and infectious disease
container_volume 43
creator Al-Tawfiq, Jaffar A.
Kheir, Hatim
Al-Dakheel, Talal
Al-Qahtani, Saeed
AlKhadra, Hussain
Sarhan, Ahlam
Bu Halaiga, Maryam
Ibrahim, Rana
description The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had caused an increased burden on healthcare organizations. Thus, a new strategy is needed to ensure all COVID-19 positive cases appropriately followed up , to receive the proper medical and psychological support, and to comply with the isolation guidelines. Here, we describe the characteristics and outcome of COVID-19 patients who were managed at home. In addition, we describe the differences between asymptomatic and those with mild symptoms. This is descriptive study of all COVID-19 positive cases who were monitored utilizing the home care concept. During the study period from June 8 to October 18, 2020, there was a total of 5368 COVID-19 patients who were referred to the home isolation/monitoring program. Of those, 2397 (45%) were female and 2971 (55%) were male. Of the total cases, 295 (5%) required hospital admission, 45 (1%) were admitted to zone 2 (an intermediate care facility), and the majority 5028 (94%) were continued in the home monitoring program till recovery. Of the total cases, 3137 (59%) were asymptomatic and the remaining 41% were symptomatic. Asymptomatic patients in comparison to symptomatic patients showed significant differences in relation to mean age (+ SD) of 31.5 (+ 18.6) and 46.45 (+ 17.1), respectively (P < 0.001)), gender, being healthcare workers, and the presence of significant medical conditions. However, a logistic regression analysis showed that only age and the presence of diabetes mellitus were associated with the presence of symptoms. The mean age (±SD) of those who required hospital admission was higher than those who were continued in home monitoring or cared for in zone 2. The utilization of home monitoring program was effective and safe in patients who were either asymptomatic or had mild symptoms.
doi_str_mv 10.1016/j.tmaid.2021.102089
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8169224</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1477893921001307</els_id><sourcerecordid>2537635352</sourcerecordid><originalsourceid>FETCH-LOGICAL-c487t-4ec455792195f2975a7927530a70380e3b2ad9f88c401d87ff5e3a20c3914c0e3</originalsourceid><addsrcrecordid>eNp9kV1rFDEUhgdRbK3-AkEC3njhrPmaTSIolPWjhULBam9Dmjmzm2UmGTOZBX-E_9mz3VrUCy9CTpLnvOfkvFX1nNEFo2z5ZrsogwvtglPO8IZTbR5Ux0wrUVMp-UOMpVK1NsIcVU-maUupaLQUj6sjIalWUurj6ufq8vr8Q80M2aQByJBiKCmHuCZjTuvshrfkDFxfNt5lICHGtHMlpIghaWEHfRoRfk2wk1hw3R5cbEkYRufLXqhsgKS5-L1-6sjV6ZerepWua44aHfgCLRlRE2KZnlaPOtdP8OxuP6m-ffr4dXVWX1x-Pl-dXtRealVqCV42jTKcmabjRjUOY9UI6hQVmoK44a41ndZeUtZq1XUNCMepF4ZJj-8n1fuD7jjfDNB6rJ1db8ccBpd_2OSC_fslho1dp53VbGk4lyjw6k4gp-8zTMUOYfLQ9y5CmifLG6GWohENR_TlP-g2zTni95BaGiqXVDKkxIHyOU1Thu6-GUbt3m67tbd2273d9mA3Zr348x_3Ob_9ReDdAQCc5i5AtpPHSXtoQ8bR2zaF_xb4BYlivNU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2569046041</pqid></control><display><type>article</type><title>COVID-19 home monitoring program: Healthcare innovation in developing, maintaining, and impacting the outcome of SARS-CoV-2 infected patients</title><source>Elsevier</source><creator>Al-Tawfiq, Jaffar A. ; Kheir, Hatim ; Al-Dakheel, Talal ; Al-Qahtani, Saeed ; AlKhadra, Hussain ; Sarhan, Ahlam ; Bu Halaiga, Maryam ; Ibrahim, Rana</creator><creatorcontrib>Al-Tawfiq, Jaffar A. ; Kheir, Hatim ; Al-Dakheel, Talal ; Al-Qahtani, Saeed ; AlKhadra, Hussain ; Sarhan, Ahlam ; Bu Halaiga, Maryam ; Ibrahim, Rana</creatorcontrib><description>The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had caused an increased burden on healthcare organizations. Thus, a new strategy is needed to ensure all COVID-19 positive cases appropriately followed up , to receive the proper medical and psychological support, and to comply with the isolation guidelines. Here, we describe the characteristics and outcome of COVID-19 patients who were managed at home. In addition, we describe the differences between asymptomatic and those with mild symptoms. This is descriptive study of all COVID-19 positive cases who were monitored utilizing the home care concept. During the study period from June 8 to October 18, 2020, there was a total of 5368 COVID-19 patients who were referred to the home isolation/monitoring program. Of those, 2397 (45%) were female and 2971 (55%) were male. Of the total cases, 295 (5%) required hospital admission, 45 (1%) were admitted to zone 2 (an intermediate care facility), and the majority 5028 (94%) were continued in the home monitoring program till recovery. Of the total cases, 3137 (59%) were asymptomatic and the remaining 41% were symptomatic. Asymptomatic patients in comparison to symptomatic patients showed significant differences in relation to mean age (+ SD) of 31.5 (+ 18.6) and 46.45 (+ 17.1), respectively (P &lt; 0.001)), gender, being healthcare workers, and the presence of significant medical conditions. However, a logistic regression analysis showed that only age and the presence of diabetes mellitus were associated with the presence of symptoms. The mean age (±SD) of those who required hospital admission was higher than those who were continued in home monitoring or cared for in zone 2. The utilization of home monitoring program was effective and safe in patients who were either asymptomatic or had mild symptoms.</description><identifier>ISSN: 1477-8939</identifier><identifier>EISSN: 1873-0442</identifier><identifier>DOI: 10.1016/j.tmaid.2021.102089</identifier><identifier>PMID: 34087448</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Age ; Asymptomatic ; Coronaviruses ; COVID-19 ; Delivery of Health Care ; Female ; Gender ; Health care ; Health Personnel ; Home monitoring program ; Hospitalization ; Hospitals ; Humans ; Infectious diseases ; Male ; Monitoring ; Original ; Pandemics ; Patients ; Quarantine ; Regression analysis ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Smartphones ; Symptoms ; Travel medicine</subject><ispartof>Travel medicine and infectious disease, 2021-09, Vol.43, p.102089-102089, Article 102089</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><rights>2021. Elsevier Ltd</rights><rights>2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c487t-4ec455792195f2975a7927530a70380e3b2ad9f88c401d87ff5e3a20c3914c0e3</citedby><cites>FETCH-LOGICAL-c487t-4ec455792195f2975a7927530a70380e3b2ad9f88c401d87ff5e3a20c3914c0e3</cites><orcidid>0000-0001-5685-7044 ; 0000-0002-5752-2235</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,778,782,883,27911,27912</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34087448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Tawfiq, Jaffar A.</creatorcontrib><creatorcontrib>Kheir, Hatim</creatorcontrib><creatorcontrib>Al-Dakheel, Talal</creatorcontrib><creatorcontrib>Al-Qahtani, Saeed</creatorcontrib><creatorcontrib>AlKhadra, Hussain</creatorcontrib><creatorcontrib>Sarhan, Ahlam</creatorcontrib><creatorcontrib>Bu Halaiga, Maryam</creatorcontrib><creatorcontrib>Ibrahim, Rana</creatorcontrib><title>COVID-19 home monitoring program: Healthcare innovation in developing, maintaining, and impacting the outcome of SARS-CoV-2 infected patients</title><title>Travel medicine and infectious disease</title><addtitle>Travel Med Infect Dis</addtitle><description>The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had caused an increased burden on healthcare organizations. Thus, a new strategy is needed to ensure all COVID-19 positive cases appropriately followed up , to receive the proper medical and psychological support, and to comply with the isolation guidelines. Here, we describe the characteristics and outcome of COVID-19 patients who were managed at home. In addition, we describe the differences between asymptomatic and those with mild symptoms. This is descriptive study of all COVID-19 positive cases who were monitored utilizing the home care concept. During the study period from June 8 to October 18, 2020, there was a total of 5368 COVID-19 patients who were referred to the home isolation/monitoring program. Of those, 2397 (45%) were female and 2971 (55%) were male. Of the total cases, 295 (5%) required hospital admission, 45 (1%) were admitted to zone 2 (an intermediate care facility), and the majority 5028 (94%) were continued in the home monitoring program till recovery. Of the total cases, 3137 (59%) were asymptomatic and the remaining 41% were symptomatic. Asymptomatic patients in comparison to symptomatic patients showed significant differences in relation to mean age (+ SD) of 31.5 (+ 18.6) and 46.45 (+ 17.1), respectively (P &lt; 0.001)), gender, being healthcare workers, and the presence of significant medical conditions. However, a logistic regression analysis showed that only age and the presence of diabetes mellitus were associated with the presence of symptoms. The mean age (±SD) of those who required hospital admission was higher than those who were continued in home monitoring or cared for in zone 2. The utilization of home monitoring program was effective and safe in patients who were either asymptomatic or had mild symptoms.</description><subject>Age</subject><subject>Asymptomatic</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Delivery of Health Care</subject><subject>Female</subject><subject>Gender</subject><subject>Health care</subject><subject>Health Personnel</subject><subject>Home monitoring program</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Monitoring</subject><subject>Original</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Quarantine</subject><subject>Regression analysis</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Smartphones</subject><subject>Symptoms</subject><subject>Travel medicine</subject><issn>1477-8939</issn><issn>1873-0442</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kV1rFDEUhgdRbK3-AkEC3njhrPmaTSIolPWjhULBam9Dmjmzm2UmGTOZBX-E_9mz3VrUCy9CTpLnvOfkvFX1nNEFo2z5ZrsogwvtglPO8IZTbR5Ux0wrUVMp-UOMpVK1NsIcVU-maUupaLQUj6sjIalWUurj6ufq8vr8Q80M2aQByJBiKCmHuCZjTuvshrfkDFxfNt5lICHGtHMlpIghaWEHfRoRfk2wk1hw3R5cbEkYRufLXqhsgKS5-L1-6sjV6ZerepWua44aHfgCLRlRE2KZnlaPOtdP8OxuP6m-ffr4dXVWX1x-Pl-dXtRealVqCV42jTKcmabjRjUOY9UI6hQVmoK44a41ndZeUtZq1XUNCMepF4ZJj-8n1fuD7jjfDNB6rJ1db8ccBpd_2OSC_fslho1dp53VbGk4lyjw6k4gp-8zTMUOYfLQ9y5CmifLG6GWohENR_TlP-g2zTni95BaGiqXVDKkxIHyOU1Thu6-GUbt3m67tbd2273d9mA3Zr348x_3Ob_9ReDdAQCc5i5AtpPHSXtoQ8bR2zaF_xb4BYlivNU</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Al-Tawfiq, Jaffar A.</creator><creator>Kheir, Hatim</creator><creator>Al-Dakheel, Talal</creator><creator>Al-Qahtani, Saeed</creator><creator>AlKhadra, Hussain</creator><creator>Sarhan, Ahlam</creator><creator>Bu Halaiga, Maryam</creator><creator>Ibrahim, Rana</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>F1W</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H95</scope><scope>H97</scope><scope>K9.</scope><scope>KB0</scope><scope>L.G</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5685-7044</orcidid><orcidid>https://orcid.org/0000-0002-5752-2235</orcidid></search><sort><creationdate>20210901</creationdate><title>COVID-19 home monitoring program: Healthcare innovation in developing, maintaining, and impacting the outcome of SARS-CoV-2 infected patients</title><author>Al-Tawfiq, Jaffar A. ; Kheir, Hatim ; Al-Dakheel, Talal ; Al-Qahtani, Saeed ; AlKhadra, Hussain ; Sarhan, Ahlam ; Bu Halaiga, Maryam ; Ibrahim, Rana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c487t-4ec455792195f2975a7927530a70380e3b2ad9f88c401d87ff5e3a20c3914c0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age</topic><topic>Asymptomatic</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Delivery of Health Care</topic><topic>Female</topic><topic>Gender</topic><topic>Health care</topic><topic>Health Personnel</topic><topic>Home monitoring program</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Monitoring</topic><topic>Original</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Quarantine</topic><topic>Regression analysis</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Smartphones</topic><topic>Symptoms</topic><topic>Travel medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Tawfiq, Jaffar A.</creatorcontrib><creatorcontrib>Kheir, Hatim</creatorcontrib><creatorcontrib>Al-Dakheel, Talal</creatorcontrib><creatorcontrib>Al-Qahtani, Saeed</creatorcontrib><creatorcontrib>AlKhadra, Hussain</creatorcontrib><creatorcontrib>Sarhan, Ahlam</creatorcontrib><creatorcontrib>Bu Halaiga, Maryam</creatorcontrib><creatorcontrib>Ibrahim, Rana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 3: Aquatic Pollution &amp; Environmental Quality</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Travel medicine and infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Tawfiq, Jaffar A.</au><au>Kheir, Hatim</au><au>Al-Dakheel, Talal</au><au>Al-Qahtani, Saeed</au><au>AlKhadra, Hussain</au><au>Sarhan, Ahlam</au><au>Bu Halaiga, Maryam</au><au>Ibrahim, Rana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 home monitoring program: Healthcare innovation in developing, maintaining, and impacting the outcome of SARS-CoV-2 infected patients</atitle><jtitle>Travel medicine and infectious disease</jtitle><addtitle>Travel Med Infect Dis</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>43</volume><spage>102089</spage><epage>102089</epage><pages>102089-102089</pages><artnum>102089</artnum><issn>1477-8939</issn><eissn>1873-0442</eissn><abstract>The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had caused an increased burden on healthcare organizations. Thus, a new strategy is needed to ensure all COVID-19 positive cases appropriately followed up , to receive the proper medical and psychological support, and to comply with the isolation guidelines. Here, we describe the characteristics and outcome of COVID-19 patients who were managed at home. In addition, we describe the differences between asymptomatic and those with mild symptoms. This is descriptive study of all COVID-19 positive cases who were monitored utilizing the home care concept. During the study period from June 8 to October 18, 2020, there was a total of 5368 COVID-19 patients who were referred to the home isolation/monitoring program. Of those, 2397 (45%) were female and 2971 (55%) were male. Of the total cases, 295 (5%) required hospital admission, 45 (1%) were admitted to zone 2 (an intermediate care facility), and the majority 5028 (94%) were continued in the home monitoring program till recovery. Of the total cases, 3137 (59%) were asymptomatic and the remaining 41% were symptomatic. Asymptomatic patients in comparison to symptomatic patients showed significant differences in relation to mean age (+ SD) of 31.5 (+ 18.6) and 46.45 (+ 17.1), respectively (P &lt; 0.001)), gender, being healthcare workers, and the presence of significant medical conditions. However, a logistic regression analysis showed that only age and the presence of diabetes mellitus were associated with the presence of symptoms. The mean age (±SD) of those who required hospital admission was higher than those who were continued in home monitoring or cared for in zone 2. The utilization of home monitoring program was effective and safe in patients who were either asymptomatic or had mild symptoms.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>34087448</pmid><doi>10.1016/j.tmaid.2021.102089</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-5685-7044</orcidid><orcidid>https://orcid.org/0000-0002-5752-2235</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1477-8939
ispartof Travel medicine and infectious disease, 2021-09, Vol.43, p.102089-102089, Article 102089
issn 1477-8939
1873-0442
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8169224
source Elsevier
subjects Age
Asymptomatic
Coronaviruses
COVID-19
Delivery of Health Care
Female
Gender
Health care
Health Personnel
Home monitoring program
Hospitalization
Hospitals
Humans
Infectious diseases
Male
Monitoring
Original
Pandemics
Patients
Quarantine
Regression analysis
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Smartphones
Symptoms
Travel medicine
title COVID-19 home monitoring program: Healthcare innovation in developing, maintaining, and impacting the outcome of SARS-CoV-2 infected patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T19%3A00%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20home%20monitoring%20program:%20Healthcare%20innovation%20in%20developing,%20maintaining,%20and%20impacting%20the%20outcome%20of%20SARS-CoV-2%20infected%20patients&rft.jtitle=Travel%20medicine%20and%20infectious%20disease&rft.au=Al-Tawfiq,%20Jaffar%20A.&rft.date=2021-09-01&rft.volume=43&rft.spage=102089&rft.epage=102089&rft.pages=102089-102089&rft.artnum=102089&rft.issn=1477-8939&rft.eissn=1873-0442&rft_id=info:doi/10.1016/j.tmaid.2021.102089&rft_dat=%3Cproquest_pubme%3E2537635352%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c487t-4ec455792195f2975a7927530a70380e3b2ad9f88c401d87ff5e3a20c3914c0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2569046041&rft_id=info:pmid/34087448&rfr_iscdi=true